Ocular Therapeutix


Ocular Therapeutix Rises 7% On Stellar Results Backed By Dextenza

Shares of Ocular Therapeutix rose 7% on Nov. 6 after the biopharma reported better-than-expected third quarter results driven by the demand for Dextenza, …

Ocular Lifted By Strong 3Q Prelim Net Product Sales

Shares of Ocular Therapeutix rose 2.1% in Wednesday’s extended market trading session after closing 28.

3 Monster Growth Stocks Primed for Further Gains

When it comes down to it, investors are focused on a single factor: a stock’s ability to deliver returns. As Wall Street observers …

Ocular Therapeutix (OCUL): ReSure Warning Letter Insignificant to Pipeline, Says Analyst

Last Friday, Ocular Therapeutix (OCUL) announced that the company had received a warning letter from the FDA. The letter relates to the company’s …

Why Analysts See Solid Upside Potential for Ocular Therapeutix (OCUL), Catalyst Pharmaceuticals (CPRX), and AcelRx (ACRX)

Ocular Therapeutix (OCUL), Catalyst Pharmaceuticals (CPRX) and AcelRx Pharmaceuticals (ACRX) look forward to important regulatory approval decisions this year. Could these catalysts give these small …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts